|1.||Hernández, Teresa: 1 article (06/2006)|
|2.||Ordóñez, Jose-Luis: 1 article (06/2006)|
|3.||de Alava, Enrique: 1 article (06/2006)|
|4.||Martins, Ana S: 1 article (06/2006)|
|5.||Mackintosh, Carlos: 1 article (06/2006)|
|6.||Campos, Maria: 1 article (06/2006)|
|7.||Martín, David Herrero: 1 article (06/2006)|
|2.||Ewing's Sarcoma (Sarcoma, Ewing)
06/01/2006 - "Inhibition of Ewing tumor cell proliferation by ADW742 is mediated through blockade of IGF1R signaling. "
06/01/2006 - "This study supports a potential role for ADW742 in the treatment of Ewing tumor and AKT/mTOR as a possible surrogate marker of response to therapy."
06/01/2006 - "We analyzed IGF1R blockade by ADW742, a small molecule specific for this receptor, alone and in combination with imatinib, vincristine, and doxorubicin on Ewing tumor cell lines. "
06/01/2006 - "Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor."
|4.||Biological Markers (Surrogate Marker)
|5.||IGF Type 1 Receptor (IGF 1 Receptor)